Researchers discover new spiroindolin-1,2-diazepine derivatives with anti-Alzheimer therapeutic potential

FHS
July 31, 2023
11:16 am

In a recent study, researchers designed substituted spiro indolin-1,2-diazepine derivatives ‘5a–v’ with cholinesterase inhibitory activities as anti-Alzheimer’s disease agents.

Marine fungus-derived aniquinazolin B could be a potential opioid alternative

Opioids have long been known as natural substances with substantial pharmacological effect. They have been used as effective painkillers.

July 17, 2024

CGM OK’d During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down

Abbott’s FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be approved for use during medical imaging,

November 6, 2024

Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.